Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Cash from Operations (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Cash from Operations data on record, last reported at 76325000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations fell 36.0% year-over-year to 76325000.0; the TTM value through Dec 2025 reached 249068000.0, down 89.04%, while the annual FY2025 figure was 249068000.0, 89.04% down from the prior year.
  • Cash from Operations reached 76325000.0 in Q4 2025 per PRAX's latest filing, down from 65057000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 20857000.0 in Q1 2024 and bottomed at 76325000.0 in Q4 2025.
  • Average Cash from Operations over 4 years is 42312750.0, with a median of 38882500.0 recorded in 2022.
  • Peak YoY movement for Cash from Operations: skyrocketed 48.32% in 2023, then tumbled 154.16% in 2025.
  • A 4-year view of Cash from Operations shows it stood at 28806000.0 in 2022, then rose by 17.17% to 23861000.0 in 2023, then crashed by 135.2% to 56122000.0 in 2024, then crashed by 36.0% to 76325000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 76325000.0 in Q4 2025, 65057000.0 in Q3 2025, and 54676000.0 in Q2 2025.